Home / Import refusals / 1FX-5209662-4/20002/1

FDA Import Refusal 1FX-5209662-4/20002/1 — CIPLA LTD

CIPLA LTD — FEI 3043729154

The FDA refused shipment 1FX-5209662-4/20002/1 from CIPLA LTD (India) on May 6, 2026. The refused product falls under Drugs and Biologics — FEBUXOSTAT (XANTHINE OXIDASE INHIBITOR). Cited charge: 75 This firm has 5 or more other import refusals on record.

Refusal Details

Date
May 6, 2026
Country
India
Product Category
Drugs and Biologics
Product Code
66TDY03 FEBUXOSTAT (XANTHINE OXIDASE INHIBITOR)
Charges
75

Other import refusals

  • 1FX-5026714-5/20002/1 (Fri Jul 10 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 1FX-4357427-6/10002/4 (Fri Jul 10 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 1FX-5554870-4/30002/1 (Thu May 14 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AEK-0349073-6/70002/1 (Mon May 04 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 1FX-3444821-6/20002/2 (Fri Apr 17 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)

FDA data resources